The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 26th 2024
Although shingles is more common in adults, children who have had chickenpox or the chickenpox vaccine can develop shingles.
How to Address Customer Concerns Regarding Uncovered Prescriptions in the Pharmacy Setting
July 16th 2021Since pharmacy is a service business, the required process of communicating and educating customers, working closely with physicians, and navigating relief programs can help patients customers address the problems and stress of receiving a denial by their insurance company.
Read More
Study: COVID-19 Vaccine Efficacy, Awareness Important to Convert Hesitant Individuals
July 16th 2021Adults unsure about receiving the COVID-19 vaccine who were given more information about the vaccine’s efficacy scored 20% higher on a measure of willingness to be vaccinated versus others who received no information.
Read More
Equal but Not the Same—2021 Update on Influenza Vaccines
As COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.
Read More
COVID-19 Antibody Study Demonstrates Importance of Second Vaccine Dose, Updates to Vaccine
July 14th 2021Vaccinated individuals overall had large amounts of antibodies present compared to infected individuals, suggesting that vaccination both protects against becoming infected and reduces the likelihood of transmitting the virus to others.
Read More
First Participant Dosed in Phase 1/2 Study of Moderna’s Quadrivalent Seasonal Flu mRNA Vaccine
July 13th 2021The study plans to enroll approximately 180 participants to evaluate the safety, reactogenicity, and immunogenicity of its quadrivalent seasonal influenza mRNA vaccine in adults 18 years and older.
Read More
Phase 2 Study Indicates Mirikizumab Induces Mucosal Healing in Patients With Ulcerative Colitis
July 12th 2021According to the investigators, gene changes unique among individuals who responded to mirikizumab indicate that mirikizumab affects a distinct molecular healing pathway when compared to the spontaneous healing that occurred among the cohort administered the placebo.
Read More